First-line panitumumab plus capecitabine for the treatment of older patients with wild-type RAS metastatic colorectal cancer. The phase II, PANEL study
Titel:
First-line panitumumab plus capecitabine for the treatment of older patients with wild-type RAS metastatic colorectal cancer. The phase II, PANEL study
Auteur:
Méndez Méndez, José Carlos Salgado Fernández, Mercedes de la Cámara Gómez, Juan Pellón Augusto, Mari Luz Covela Rua, Marta Quintero Aldana, Guillermo Fernández Montes, Ana Reboredo López, Margarida Valladares Ayerbes, Manuel Jorge Fernández, Mónica González Villarroel, Paula Romero Reinoso, Carlos Ramos Vázquez, Manuel